289
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Trends and characteristics of fetal and neonatal mortality due to congenital anomalies, Colombia 1999–2008

, , , , &
Pages 1748-1755 | Received 06 Mar 2017, Accepted 02 May 2017, Published online: 22 May 2017

References

  • World Health Organization. Congenital anomalies; 2015 [Internet]. Available from: http://www.who.int/mediacentre/factsheets/fs370/en/
  • Rosano A, Botto LD, Botting B, et al. Infant mortality and congenital anomalies from 1950 to 1994: an international perspective. J Epidemiol Commun Health. 2000;54:660–666.
  • World Health Organization. Millennium Development Goals 4 and 5 [Internet]. Available from: http://www.who.int/pmnch/about/about_mdgs/en/ (last accessed 5 Nov 2011).
  • Organización Panamericana de la Salud. Datos de Mortalidad para Salud en las Américas 2012; 2012 [Internet]. Available from: http://www.paho.org/hq/index.php?-option=com_content&view=article&id=5605&catid=2391%3Adatabases&Itemid=2392&lang=es
  • Baltaxe E, Zarante I. Prevalence of congenital heart disease in 44,985 newborns in Colombia. Archiv Cardiol Mex. 2006;76:263–268.
  • Zarante I, Franco L, López C, et al. Frequencies of congenital malformations: assessment and prognosis of 52,744 births in three cities of Colombia. Biomedica. 2010;30:65–71.
  • Barboza-Arguello MDLP, Umana-Solis LM. Analisis de diez anos de registro de malformaciones congenitas en Costa Rica (Ten year analysis of the national registry of congenital anomalies in Costa Rica). Acta Med Costarricense. 2008;50:221–229.
  • Zeng Z, Zhang H, Liu F, et al. Current diagnosis and treatments for critical congenital heart defects (Review). Exp Ther Med. 2016;11:1550–1554.
  • Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med. 1999;341:1485–1490.
  • Blencowe H, Cousens S, Modell B, et al. Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol. 2010;39:i110–i121.
  • Crider KS, Devine O, Hao L, et al. Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ (Online). 2014;349:g4554. doi: 10.1136/bmj.g4554
  • Castillo-Lancellotti C, Tur JA, Uauy R. Impact of folic acid fortification of flour on neural tube defects: a systematic review. Public Health Nutr. 2013;16:901–911.
  • Rosenthal J, Casas J, Taren D, et al. Neural tube defects in Latin America and the impact of fortification: a literature review. Public Health Nutr. 2014;17:537–550.
  • Santos LMP, Lecca RCR, Cortez-Escalante JJ, et al. Prevention of neural tube defects by the fortification of flour with folic acid: a population-based retrospective study in Brazil. Bull World Health Organ. 2016;94:22–29.
  • Williams J, Mai CT, Mulinare J, et al. Updated estimates of neural tube defects prevented by mandatory folic acid fortification — United States, 1995–2011. Morbid Mortal Week Rep. 2015;64:1–5.
  • Government of Colombia. DECRETO NÚMERO 1944 DE 1996 (Octubre 28) por el cual se reglamenta la fortificación de la harina de trigo y se establecen las condiciones de comercialización, rotulado, vigilancia y control; 1996 [Internet]. Available from: https://www.invima.gov.co/images/stories/aliementos/decreto_1944_1996.pdf
  • Cordero AM, Crider KS, Rogers LM, et al. Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects: World health organization guidelines. Morbid Mortal Week Rep. 2015;64:421–423.
  • Rosenthal J, Lopez-Pazos E, Dowling NF, et al. Folate and Vitamin B12 deficiency among non-pregnant women of childbearing-age in Guatemala 2009–2010: prevalence and identification of vulnerable populations. Matern Child Health J. 2015;19:2272–2285.
  • Taucher E, Icaza G. Infant mortality differentials from congenital malformations with paired data. Rev Med Chile. 2001;129:405–412.
  • Coory MD, Roselli T, Carroll HJ. Antenatal care implications of population-based trends in Down syndrome birth rates by rurality and antenatal care provider, Queensland, 1990–2004. Med J Aust. 2007;186:230–234.
  • Kiely JL, Paneth N, Susser M. An assessment of the effects of maternal age and parity in different components of perinatal mortality. Am J Epidemiol. 1986;123:444–454.
  • Chen XK, Wen SW, Fleming N, et al. Teenage pregnancy and congenital anomalies: which system is vulnerable? Hum Reprod. 2007;22:1730–1735.
  • Reefhuis J, Honein MA. Maternal age and non-chromosomal birth defects, Atlanta – 1968–2000: teenager or thirty-something, who is at risk? Birth Defect Res A. 2004;70:572–579.
  • Gordon A, Raynes-Greenow C, McGeechan K, et al. Risk factors for antepartum stillbirth and the influence of maternal age in New South Wales Australia: a population based study. BMC Pregnancy Childbirth. 2013;13:12. doi: 10.1186/1471-2393-13-12
  • Lisi A, Botto LD, Rittler M, et al. Sex and congenital malformations: an international perspective. Am J Med Genet. 2005;134A:49–57.
  • Cockerill R, Whitworth MK, Heazell AEP. Do medical certificates of stillbirth provide accurate and useful information regarding the cause of death? Paediatr Perinat Epidemiol. 2012;26:117–123.
  • Walker S, Rampatige R, Wainiqolo I, et al. An accessible method for teaching doctors about death certification. Health Inform Manage J. 2012;41:4–10.
  • Christianson A, Howson CP, Modell B. Global report on birth defects: the hidden toll of dying and disabled children. White Plains (NY): March of Dimes Foundation; 2006.
  • Banerjee E, Zabel E, Alexander B. Comparison of defects identified through Minnesota’s Birth Defects Information System And Vital Records, 2006–2008. J Reg Manage. 2012;39:8–12.
  • Gupta N, Bharti B, Singhi S, et al. Errors in filling WHO death certificate in children: lessons from 1251 death certificates. J Trop Pediatr. 2014;60:74–78.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.